The efficacy and safety of short-acting, full agonist opioids for symptom management of opioid withdrawal
Addictive Behaviors Reports · 2026-06 · 23 · 100691
DOI: 10.1016/j.abrep.2026.100691 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Addictive Behaviors Reports, 2026-06. Verfasst von Pouya Azar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vancouver General Hospital, Vancouver, British Columbia, Canada. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: VGH and UBC Hospital Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Vancouver General Hospital, Vancouver, British Columbia, Canada.
- Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.
- Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Förderung
- VGH and UBC Hospital Foundation
Zitieren
APA
Azar, P., Kim, J. J., Wong, J., Machado, J., Budd, G., Baldwin, K., Siu, J. T. P., & Lau, A. (2026). The efficacy and safety of short-acting, full agonist opioids for symptom management of opioid withdrawal. Addictive Behaviors Reports, 23, 100691. https://doi.org/10.1016/j.abrep.2026.100691
Vancouver
Azar P, Kim JJ, Wong J, Machado J, Budd G, Baldwin K, et al. The efficacy and safety of short-acting, full agonist opioids for symptom management of opioid withdrawal. Addictive Behaviors Reports. 2026;23:100691. doi:10.1016/j.abrep.2026.100691
BibTeX
@article{Azar2026,
author = {Azar, Pouya and Kim, Jane J and Wong, Jade and Machado, Jessica and Budd, George and Baldwin, Kaitlyn and Siu, Jacky T P and Lau, Anthony},
title = {The efficacy and safety of short-acting, full agonist opioids for symptom management of opioid withdrawal},
journal = {Addictive Behaviors Reports},
year = {2026},
volume = {23},
pages = {100691},
doi = {10.1016/j.abrep.2026.100691}
}
EUVIMED